Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12054555 | Anti-BAFFR antibody formulations and methods of use thereof | Marta Cosenza, Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2024-08-06 |
| 12018072 | Antibodies specific for human complement C5A receptor (C5AR) | Barbara Bachler-Konetzki, Tanja Herrmann, Winfried Elis | 2024-06-25 |
| 11542329 | Antibodies targeting Glycoprotein VI | Kerstin Uhland, Steffen Runz | 2023-01-03 |
| 11472880 | Humanized antibodies for CD3 | Thomas Tiller, Steffen Runz, Andreas Bültmann | 2022-10-18 |
| 11254734 | Fab molecules with a rodent hinge region and a non-rodent CH1 region | Steffen Runz, Stefanie Urlinger | 2022-02-22 |
| 10899841 | Anti-BAFFR antibody formulations and methods of use thereof | Marta Cosenza, Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2021-01-26 |
| 9988443 | Angiopoetin-like 4 (ANGPTL4) antibodies and methods of use | John Trauger, Andrei I. Voznesensky, Steffen Runz | 2018-06-05 |
| 9988455 | Methods of treating cardiovascular disorders with lectin-like oxidized LDL receptor 1 antibodies | Kurt Alex HELDWEIN, Jennifer Brogdon, William Dole, John Trauger, Yuting Tang +1 more | 2018-06-05 |
| 9562101 | Lectin-like oxidized LDL receptor 1 antibodies and methods of use | Kurt Alex HELDWEIN, Jennifer Brogdon, William Dole, John Trauger, Yuting Tang +1 more | 2017-02-07 |
| 9458240 | Anti-BAFFR antibody formulations | Marta Cosenza, Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2016-10-04 |
| 9382326 | Compositions and methods of use for therapeutic antibodies | Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2016-07-05 |
| 9340620 | Compositions and methods of use for therapeutic antibodies | Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2016-05-17 |
| 8106163 | Compositions and methods of use for therapeutic antibodies | Christoph Heusser, Eveline Schaadt, Stefanie Urlinger, Maximilian Woisetschlaeger | 2012-01-31 |